Skip to main content
eScholarship
Open Access Publications from the University of California

UCLA

UCLA Electronic Theses and Dissertations bannerUCLA

High Throughput Screening of Biologically Functional Small Molecules for Modulating the Expression of FGFR1OP2/wit3.0 in Fibroblasts

  • Author(s): Cheng, William J.
  • Advisor(s): Nishimura, Ichiro
  • et al.
Abstract

Objectives: In skin wounds, inflammation associated cytokines and growth factors induce fibroblasts to undergo transdifferentiation allowing them to contract the wound. Though wounds in the oral cavity heal with a lesser degree of inflammation, they contract at a faster pace and exhibit reduced scarring compared to the skin. FGFR1OP2/wit3.0 is a small cytoplasmic peptide highly expressed by oral wound fibroblasts, but not by skin wound fibroblasts. In this study we aim to determine the exogenous factors possibly inducing FGFR1OP2/wit3.0 expression in skin fibroblasts through the development of a high throughput screening assay.

Methods: This study examined the use of direct mRNA measurement assays for use in high throughput applications to find chemical agents that up or downregulate FGFR1OP2/wit3.0 expression. Using mouse clonal fibroblastic cell lines we characterized genetic expression, phenotype, and si-RNA knockdown of wit3.0. We then developed and optimized a protocol for high throughput screening on a bDNA platform. A pilot screening was performed at the UCLA MSSR.

Results: Confocal microscopy revealed that the cytoskeletal arrangement of actin and wit3.0 were phenotypically different in the heterozygous knockout stem cell derived fibroblasts. wit3.0 (+/-) cells exhibited disorganized actin fibers, while the wildtype showed a more organized archetype. We found that wit3.0 was expressed in both L-929 and C3H/10T1/2 and appears in immunostaining as a cytoplasmic, granular protein. We were able to successfully perform a high throughput screening of 320 chemicals as a pilot study, and identified 7 compounds as modulators of wit3.0.

Conclusion: This pilot study has identified biologically functional chemical compounds which could provide a novel clue in elucidating the mechanism of fibroblast-driven wound closure, and presents a new therapeutic potential in the field of wound healing.

Main Content
For improved accessibility of PDF content, download the file to your device.
Current View